Academic Journal
Combination of everolimus and itacitinib in patients with Hodgkin lymphoma relapsed/refractory to brentuximab vedotin (BV) and checkpoint inhibitors (CPI)
العنوان: | Combination of everolimus and itacitinib in patients with Hodgkin lymphoma relapsed/refractory to brentuximab vedotin (BV) and checkpoint inhibitors (CPI) |
---|---|
المؤلفون: | Svoboda, J., Landsburg, D. L., Nasta, S. D., Barta, S. K., Chong, E. A., Carter, J., Delp, G., Duca, A., Ballard, H. J., Emanuel, S. A., McWilliams, T., Hwang, W., Hughes, M. E., Ruella, M., Schuster, S. J. |
المصدر: | Hematological Oncology ; volume 41, issue S2, page 594-595 ; ISSN 0278-0232 1099-1069 |
بيانات النشر: | Wiley |
سنة النشر: | 2023 |
المجموعة: | Wiley Online Library (Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1002/hon.3164_445 |
الاتاحة: | http://dx.doi.org/10.1002/hon.3164_445 https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3164_445 |
Rights: | http://onlinelibrary.wiley.com/termsAndConditions#vor |
رقم الانضمام: | edsbas.5D806695 |
قاعدة البيانات: | BASE |
DOI: | 10.1002/hon.3164_445 |
---|